Release Date: 22/12/22 16:20 Summary: Estimated Distribution Announcement - Dec 2022 Price Sensitive: Yes Download Document 145.13KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%